North America Poultry Vaccines Market: By Vaccine Type (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), By Formulation (Dry Form (Duct) Vaccines, Liquid Vaccines, Freeze Dried Vaccines), By Application (Marek's Disease, Newcastle Disease, Infectious Bursal Disease, Infectious Bronchitis, Others) and Country

Purchase Option

$ 3100
$ 4600
$ 6900

North America Poultry Vaccines Market size was valued at USD x billion in 2023 and is poised to grow at a CAGR of x% from 2024-2030. Vaccines are biological preparations that provide acquired immunity to particular diseases in human beings or animals. Poultry vaccines are used to prevent or cure various diseases in poultry such as Marek's disease, Newcastle disease, and infectious diseases among others. However, stringent regulatory guidelines for vaccine approvals, adverse effects associated with vaccines, and high costs for R&D activities may restrain the growth of the poultry vaccines market in future years.  Any type of domesticated bird bred in captivity for its usefulness is referred to as poultry. Historically, the term has only been used to apply to waterfowl (Anseriformes) and wildfowl (Galliformes), not cagebirds like parrots and songbirds. The term "poultry" refers to domestic birds, such as chickens, turkeys, geese, and ducks, that are raised for their meat or eggs. It also refers to the bird flesh that is consumed.

North America Poultry Vaccines Market Dynamics

Increase in the demand for healthy meat and poultry products, rise in R&D activities for the innovation of newer poultry vaccines, escalation in prevalence of various diseases such as avian flu in poultry, and high awareness about the poultry diseases among veterinary professionals are expected to boost the North America poultry vaccines market over the forecast period.

North America Poultry Vaccines Market Segmentation

By Vaccine Type
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines
By Formulation
  • Dry Form (Duct) Vaccines
  • Liquid Vaccines
  • Freeze Dried Vaccines
By Application
  • Marek's Disease
  • Newcastle Disease
  • Infectious Bursal Disease
  • Infectious Bronchitis
  • Others

Frequently Asked Questions

2023 is the base year and 2030 is the forecast year.

The north america poultry vaccines market report covers the market data: United States, Canada

The north america poultry vaccines market key players are Arko Laboratories, Merck & Co. Inc., Boehringer Ingelheim Vetmedica, Elanco, Bayer Animal Health, Ceva Sante Animale, Zydus AHL, Phibro Animal Health Corporation

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1.Executive Summary
2. North America Poultry Vaccines Market Introduction 
2.1. North America Poultry Vaccines Market  - Taxonomy
2.2. North America Poultry Vaccines Market  - Definitions
2.2.1.Vaccine Type
2.2.2.Formulation
2.2.3.Application
2.2.4.Country
3. North America Poultry Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. North America Poultry Vaccines Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. North America Poultry Vaccines Market  By Vaccine Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Inactivated Vaccines
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Live Attenuated Vaccines
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Recombinant Vaccines
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. North America Poultry Vaccines Market  By Formulation, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Dry Form (Duct) Vaccines
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Liquid Vaccines
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Freeze Dried Vaccines
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. North America Poultry Vaccines Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Marek's Disease
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Newcastle Disease
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Infectious Bursal Disease
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Infectious Bronchitis
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Others
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. North America Poultry Vaccines Market  By Country, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. United States of America (USA)
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Canada
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
9.United States of America (USA) Poultry Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Inactivated Vaccines
9.1.2.Live Attenuated Vaccines
9.1.3.Recombinant Vaccines
9.2.  Formulation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Dry Form (Duct) Vaccines
9.2.2.Liquid Vaccines
9.2.3.Freeze Dried Vaccines
9.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Marek's Disease
9.3.2.Newcastle Disease
9.3.3.Infectious Bursal Disease
9.3.4.Infectious Bronchitis
9.3.5.Others
10.Canada Poultry Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Vaccine Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Inactivated Vaccines
10.1.2.Live Attenuated Vaccines
10.1.3.Recombinant Vaccines
10.2.  Formulation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Dry Form (Duct) Vaccines
10.2.2.Liquid Vaccines
10.2.3.Freeze Dried Vaccines
11. Competition Landscape
11.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
11.2.1.Bayer Animal Health
11.2.2.Ceva Sante Animale
11.2.3.Boehringer Ingelheim Vetmedica
11.2.4.Elanco
11.2.5.Zoetis
11.2.6.Zydus AHL
12. Research Methodology 
13. Appendix and Abbreviations 
  • Zoetis (Pfizer, Inc.
  • Merck & Co. Inc.
  • Boehringer Ingelheim Vetmedica
  • Elanco
  • Bayer Animal Health
  • Ceva Sante Animale
  • Zydus AHL
  • Arko Laboratories
  • Phibro Animal Health Corporation

Adjacent Markets